Nucleofection-Mediated α1,3-galactosyltransferase Gene Inactivation and Membrane Cofactor Protein Expression for Pig-to-Primate Xenotransplantation
Xenotransplantation of pig organs into primates leads to hyperacute rejection (HAR). Functional ablation of the pig α1,3-galactosyltransferase (GalT) gene, which abrogates expression of the Galα1-3Galβ1-4GlcNAc-R (Gal) antigen, which inhibits HAR. However, antigens other than Gal may induce immunolo...
Saved in:
Published in | Animal biotechnology Vol. 24; no. 4; pp. 253 - 267 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis Group
2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Xenotransplantation of pig organs into primates leads to hyperacute rejection (HAR). Functional ablation of the pig α1,3-galactosyltransferase (GalT) gene, which abrogates expression of the Galα1-3Galβ1-4GlcNAc-R (Gal) antigen, which inhibits HAR. However, antigens other than Gal may induce immunological rejection by their cognate antibody responses. Ultimately, overexpression of complement regulatory proteins reduces acute humoral rejection by non-Gal antibodies when GalT is ablated. In this study, we developed a vector-based strategy for ablation of GalT function and concurrent expression of membrane cofactor protein (MCP, CD46). We constructed an MCP expression cassette (designated as MCP-IRESneo) and inserted between the left and the right homologous arms to target exon 9 of the GalT gene. Nucleofection of porcine ear skin fibroblasts using the U-023 and V-013 programs resulted in high transfection efficiency and cell survival. We identified 28 clones in which the MCP-IRESneo vector had been successfully targeted to exon 9 of the GalT gene. Two of those clones, with apparent morphologically mitotic fibroblast features were selected through long-term culture. GalT gene expression was downregulated in these 2 clones. Importantly, MCP was shown to be efficiently expressed at the cell surface and to efficiently protect cell lysis against normal human complement serum attack in vitro. |
---|---|
Bibliography: | http://dx.doi.org/10.1080/10495398.2012.752741 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1532-2378 1049-5398 1532-2378 |
DOI: | 10.1080/10495398.2012.752741 |